2018 Disease RNA Targeted Protein Degradation 
Drug Discovery World
JANUARY 3, 2023
Targeted protein degradation and related modalities. A new modality where DEL screening has had particular impact is targeted protein degradation (TPD), a modality that has generated rapidly increasing interest in recent years. SLAS Discovery (2018). Brown DG, et al. Disch JS, et al. link] .
Drug Discovery World
MAY 30, 2023
From antibody-drug conjugates and RNA, to CRISPR and CAR-T therapy, DDW asked the drug discovery industry what the most important development in oncology over the last five years has been. At PhoreMost, we have been particularly excited about the emergence of targeted protein degradation (TPD) as a new therapeutic modality.
Expert insights. Personalized for you.
130 
Let's personalize your content